Ergoteles’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,859
| Closed | -$624K | – | 1689 |
|
|
2023
Q1 | $624K | Buy |
+6,859
| New | +$624K | 0.02% | 657 |
|
|
2022
Q4 | – | Sell |
-11,374
| Closed | -$286K | – | 2052 |
|
|
2022
Q3 | $286K | Buy |
+11,374
| New | +$286K | 0.01% | 1005 |
|
|
2022
Q1 | – | Sell |
-45,955
| Closed | -$1.21M | – | 1731 |
|
|
2021
Q4 | $1.21M | Buy |
+45,955
| New | +$1.21M | 0.05% | 365 |
|
|
2020
Q4 | – | Sell |
-28,200
| Closed | -$2.75M | – | 964 |
|
|
2020
Q3 | $2.75M | Buy |
+28,200
| New | +$2.75M | 0.36% | 54 |
|